Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. (MDNA) Q2 2022 Results Earnings Conference Call November 12, 2021, 08:30 AM ET Company Participants Dan Ferry - Managing Director-LifeSci Advisors Fahar Merchant - President & Chief Executive Officer Mann Muhsin - Chief Medical Officer Rosemina Merchant - Chief Development Officer Liz Williams - Chief Financial Officer Conference Call Participants Matt Biegler - Oppenheimer David Martin - Bloom Burton Kumar Raja - Brookline Capital David Bautz - Zacks Small-Cap Research Presentation Operator Hello, and welcome to Medicenna Therapeutics Fiscal Q2 Earnings Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised this call is being recorded at the company's request. I would now like to turn the call over to Dan Ferry of LifeSci Advisors. Please go ahead. Dan Ferry Thank you, operator and thank you all for participating in today's conference call.

For further details see:

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Medicenna Therapeutics Corp.
Stock Symbol: MDNA
Market: NASDAQ
Menu
MDNA MDNA Quote MDNA Short MDNA News MDNA Articles MDNA Message Board
Get MDNA Alerts

News, Short Squeeze, Breakout and More Instantly...